Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (24)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Azevedo, L.
Right arrow Articles by Sabbaga, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Azevedo, L.
Right arrow Articles by Sabbaga, E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrology Dialysis Transplantation, Vol 13, Issue 11 2894-2898, Copyright © 1998 by Oxford University Press


ORIGINAL ARTICLES

Renal transplantation in systemic lupus erythematosus. A case control study of 45 patients

L Azevedo, J Romao, D Malheiros, L Saldanha, L Ianhez and E Sabbaga
Unidade de Transplante Renal, Hospital das Clínicas, Av Eneas Carvalho Aguiar 255, Caixa Postal 3671, 01060-970 São Paulo-SP, Brazil; Corresponding author

Background: Outcome and the issue of recurrence of disease in systemic lupus erythematosus (SLE) renal transplant recipients is still a matter of controversy. There is a lack of comparative studies with non-SLE patients. The aim of this paper is to compare renal transplantation in lupus patients with a similar matched non-SLE group. Methods: Forty-five patients with systemic lupus erythematosus subjected to 48 kidney transplants were studied. For comparative purposes, a case-control population was selected, matched for gender, race, type of donor, age, and time of transplantation. Patients with non-glomerulonephritis diseases were excluded. Results: No differences in acute episodes of rejection, causes of kidney loss or patient death were observed. General as well as infectious complications were similar. Pregnancy rates and outcomes were similar with no deleterious effect on patients or grafts. Actuarial 1- and 5-year patient survivals (97.7 and 91.1% for SLE and 95.4 and 87% for controls, respectively) and graft survivals (93.1 and 80.7% for SLE and 88.8 and 70.2% for controls, respectively) were similar. Long-term renal function expressed by serum creatinine was the same. No differences in immunosuppressive drug (azathioprine, prednisone, and cyclosporin) requirements were found. Clinical SLE recurrence was suspected only once (a patient with thrombocytopenia, hypocomplementaemia with low complement levels and positive antiplatelet antibodies). Two SLE patients showed mesangial proliferative glomerulonephritis compatible with recurrence. Both grafts were lost. Two further patients showed membranous glomerulonephritis with an immunofluorescence pattern compatible with recurrence. A fifth patient had necrotizing arteritis which recovered after treatment with cyclophosphamide and another patient showed focal and segmental glomerulosclerosis. Histology of biopsies from five patients in the control group showed signs compatible with recurrence of focal and segmental glomerulosclerosis and membranous glomerulonephritis. There was a wide variation in serum levels of antinuclear antibodies. A wide variation in complement levels was also observed, but with a tendency toward low C4 levels. Conclusions: The safety of renal transplantation in SLE patients is equivalent to a matched case-control group with a similar rate of recurrence of disease. Key words: renal transplantation; systemic lupus erythematosus
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CJASNHome page
S. M. Meehan, A. Chang, A. Khurana, R. Baliga, P. V. Kadambi, and B. Javaid
Pauci-immune and Immune Glomerular Lesions in Kidney Transplants for Systemic Lupus Erythematosus
Clin. J. Am. Soc. Nephrol., September 1, 2008; 3(5): 1469 - 1478.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
T. Yu, Y. Chen, J. Lan, C. Cheng, C. Chen, M. Wu, and K. Shu
Renal outcome and evolution of disease activity in Chinese lupus patients after renal transplantation
Lupus, July 1, 2008; 17(7): 687 - 694.
[Abstract] [PDF]


Home page
Nephrol Dial TransplantHome page
M. Chelamcharla, B. Javaid, B. C. Baird, and A. S. Goldfarb-Rumyantzev
The outcome of renal transplantation among systemic lupus erythematosus patients
Nephrol. Dial. Transplant., December 1, 2007; 22(12): 3623 - 3630.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
F Perfumo and A Martini
Lupus nephritis in children
Lupus, January 1, 2005; 14(1): 83 - 88.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.